Insiders · Profile

Chan Mitchell

Director at Avalo Therapeutics. Filing since 6 May 2026. CIK 0001789335

Company

Date

Role

Action

Shares

Amount

Of holding

AVTX Avalo Therapeutics, Inc.

6 May 2026

Director

Sold on a plan

3,167

$72.46K

50.0%

1 decision on file.